Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has released a product line of edibles and topical gels targeting the health and wellness market.
On Monday, the company announced its Plant Precision brand which aims to fill the demand for low-dose THC formats after its recent survey results. Curaleaf found that 69 per cent of participants said they would be more likely to use cannabis as a health solution if it came in small controlled doses.
The product line will include gummy edibles with customizable doses of THC and other cannabinoids such as CBD, CBG, CBN and THCV.
The product line has five different options including an apple-flavoured gummy will low doses of THC and CBD for “waking up, winding down or providing a moment of calm”; A CBN and THC cherry-flavoured gummy for sleep (Slumber); A pineapple-flavoured gummy containing CBG and THC and a lemon-flavoured gummy with THCV “for starting your day with a little extra buzz”.
The brand will launch at Curaleaf locations in five states starting now through August. The gummies and the gel are available in Arizona and Massachusetts and the gel is available in Florida, Nevada and Utah.
“With Plant Precision we wanted to create a simplified way people can incorporate cannabis into their daily health and wellness routines,” CEO Matt Darin said.
“These products empower people to explore cannabis beyond THC and CBD and offers more customizable solutions on how the plant can best serve a consumer’s personalized needs.”
Read more: Curaleaf launches limited-edition craft cannabis product series
Read more: People consume cannabis to address health and wellness concerns: Curaleaf survey
